Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Carlsmed, Inc. ( (CARL) ) has shared an update.
On October 29, 2025, Carlsmed, Inc. amended its Loan and Security Agreement with Customers Bank, securing a credit facility that includes a $50 million term loan and a $10 million revolving line of credit. The amendment also modifies warrants previously issued to Customers Bank, reducing the number of shares exercisable under the Series B and Series C Warrants, thereby canceling rights to exercise for 15,831 shares of common stock. This financial restructuring aims to support Carlsmed’s operational flexibility and growth potential, contingent upon achieving certain revenue milestones.
The most recent analyst rating on (CARL) stock is a Buy with a $21.00 price target. To see the full list of analyst forecasts on Carlsmed, Inc. stock, see the CARL Stock Forecast page.
More about Carlsmed, Inc.
Average Trading Volume: 120,915
Current Market Cap: $332.5M
See more insights into CARL stock on TipRanks’ Stock Analysis page.